BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34315041)

  • 41. Design, synthesis and molecular docking of benzophenone conjugated with oxadiazole sulphur bridge pyrazole pharmacophores as anti inflammatory and analgesic agents.
    Zabiulla ; Gulnaz AR; Mohammed YHE; Khanum SA
    Bioorg Chem; 2019 Nov; 92():103220. PubMed ID: 31493708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aroylpropionic acid based 2,5-disubstituted-1,3,4-oxadiazoles: synthesis and their anti-inflammatory and analgesic activities.
    Akhter M; Husain A; Azad B; Ajmal M
    Eur J Med Chem; 2009 Jun; 44(6):2372-8. PubMed ID: 18977556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1, 5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents.
    De Simone R; Chini MG; Bruno I; Riccio R; Mueller D; Werz O; Bifulco G
    J Med Chem; 2011 Mar; 54(6):1565-75. PubMed ID: 21323313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent updates on biological activities of oxadiazoles.
    Saha R; Tanwar O; Marella A; Alam MM; Akhter M
    Mini Rev Med Chem; 2013 Jun; 13(7):1027-46. PubMed ID: 22512577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expression.
    Guerrero MD; Aquino M; Bruno I; Terencio MC; Paya M; Riccio R; Gomez-Paloma L
    J Med Chem; 2007 May; 50(9):2176-84. PubMed ID: 17407277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Multi-step Virtual Screening Protocol for the Identification of Novel Non-acidic Microsomal Prostaglandin E
    Shekfeh S; Çalışkan B; Fischer K; Yalçın T; Garscha U; Werz O; Banoglu E
    ChemMedChem; 2019 Jan; 14(2):273-281. PubMed ID: 30537167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rotational constriction of curcuminoids impacts 5-lipoxygenase and mPGES-1 inhibition and evokes a lipid mediator class switch in macrophages.
    Rao Z; Caprioglio D; Gollowitzer A; Kretzer C; Imperio D; Collado JA; Waltl L; Lackner S; Appendino G; Muñoz E; Temml V; Werz O; Minassi A; Koeberle A
    Biochem Pharmacol; 2022 Sep; 203():115202. PubMed ID: 35932797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of novel microsomal prostaglandin E
    Lauro G; Manfra M; Pedatella S; Fischer K; Cantone V; Terracciano S; Bertamino A; Ostacolo C; Gomez-Monterrey I; De Nisco M; Riccio R; Novellino E; Werz O; Campiglia P; Bifulco G
    Eur J Med Chem; 2017 Jan; 125():278-287. PubMed ID: 27688183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
    Koeberle A; Werz O
    Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
    Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
    Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study.
    Abdelgawad MA; Labib MB; Abdel-Latif M
    Bioorg Chem; 2017 Oct; 74():212-220. PubMed ID: 28865292
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and biological screening of 5-(alkyl(1H-indol-3-yl))-2-(substituted)-1,3,4-oxadiazoles as antiproliferative and anti-inflammatory agents.
    Rapolu S; Alla M; Bommena VR; Murthy R; Jain N; Bommareddy VR; Bommineni MR
    Eur J Med Chem; 2013 Aug; 66():91-100. PubMed ID: 23792319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Common structural and pharmacophoric features of mPGES-1 and LTC4S.
    Devi NS; Paragi-Vedanthi P; Bender A; Doble M
    Future Med Chem; 2018 Feb; 10(3):259-268. PubMed ID: 29355395
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and molecular modeling of novel aryl carboximidamides and 3-aryl-1,2,4-oxadiazoles derived from indomethacin as potent anti-inflammatory iNOS/PGE2 inhibitors.
    Mohamed MFA; Marzouk AA; Nafady A; El-Gamal DA; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Moustafa AH
    Bioorg Chem; 2020 Dec; 105():104439. PubMed ID: 33161252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A review on mPGES-1 inhibitors: From preclinical studies to clinical applications.
    Bergqvist F; Morgenstern R; Jakobsson PJ
    Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106383. PubMed ID: 31698145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery and biological evaluation of a novel class of dual microsomal prostaglandin E2 synthase-1/5-lipoxygenase inhibitors based on 2-[(4,6-diphenethoxypyrimidin-2-yl)thio]hexanoic acid.
    Hieke M; Greiner C; Dittrich M; Reisen F; Schneider G; Schubert-Zsilavecz M; Werz O
    J Med Chem; 2011 Jul; 54(13):4490-507. PubMed ID: 21591611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and multiparametric evaluation of thiadiazoles and oxadiazoles as diacylglycerol acyltransferase type 1 inhibitors.
    Mougenot P; Namane C; Fett E; Goumy F; Dadji-Faïhun R; Langot G; Monseau C; Onofri B; Pacquet F; Pascal C; Crespin O; Ben-Hassine M; Ragot JL; Van-Pham T; Philippo C; Chatelain-Egger F; Péron P; Le Bail JC; Guillot E; Chamiot-Clerc P; Chabanaud MA; Pruniaux MP; Ménegotto J; Schmidt F; Venier O; Viviani F; Nicolai E
    Bioorg Med Chem Lett; 2016 Jan; 26(1):25-32. PubMed ID: 26627579
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modified acidic nonsteroidal anti-inflammatory drugs as dual inhibitors of mPGES-1 and 5-LOX.
    Elkady M; Nieß R; Schaible AM; Bauer J; Luderer S; Ambrosi G; Werz O; Laufer SA
    J Med Chem; 2012 Oct; 55(20):8958-62. PubMed ID: 22992107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.